Monitoring Patients With Mild/Moderate Multiple Sclerosis


The key opinion leaders provide recommendations on the optimal frequency for evaluating disease progression in patients with mild to moderate MS, emphasizing effective monitoring methods and the most appropriate tools for best clinical practice.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.